spacer
home > white papers > Considerations for Choosing the Right Wearable Drug Delivery System - West Pharmaceutical Services, Inc.
WHITE PAPERS
logo_West_Pharm6.jpg

West Pharmaceutical Services, Inc.

phone America +1 610 594 2900
web http://www.westpharma.com
email 530 Herman O. West Drive Exton, PA 19341

Considerations for Choosing the Right Wearable Drug Delivery System

For patients with chronic conditions, the use of injectable biologic therapies is on the rise. Biologics, while providing considerable therapeutic benefit, can also present several challenges for both drug manufacturers and patients. In particular, many biologics are highly viscous and others require large doses to be injected slowly over time. This can make it difficult to deliver a consistent dose every time, potentially impacting medication adherence.
Considerations for Choosing the Right Wearable Drug Delivery System
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Gerresheimer and Merck Transform Primary Packaging into Digital Twins

Gerresheimer and Merck Transform Primary Packaging into Digital Twins Proof of Concept (PoC) successfully provides primary packaging with a unique ID to access its own trustworthy digital twin. Users gain immediate access to quality and process data of products at the item level. Digital authenticity and trust are ensured through patented crypto anchors and digital certificates.
More info >>


White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement